Case Study
WuXi STA has built an integrated new modality CRDMO platform with our experienced oligonucleotide and peptide teams. This video demonstrated an example of our integrated platform…
WuXi STA has built an integrated new modality CRDMO platform with our experienced oligonucleotide and peptide teams. This video demonstrated an example of our integrated platform accelerating our client’s PPMO project in 11 months
Keep reading
Process mass intensity (PMI) is one of the most important metrics in sustainable manufacturing. It measures the total mass of raw materials required to produce a given mass of product. In…
As GLP-1 receptor agonists continue to redefine treatment for metabolic diseases, drug developers are racing to bring new and more complex therapies to the clinic. But innovation alone is…
A new publication by MSD in Organic Process Research & Development details the process development and large-scale manufacturing of the key Northern Fragment of Enlicitide Decanoate.
How can we help?
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA